Global Eye Disorders Treatments Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Eye Disorders Treatments Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Cataract Surgery Devices
  • 1.4.3 Glaucoma Surgery Devices
  • 1.4.4 Vitreoretinal Surgery Devices
  • 1.4.5 Refractive Surgery Devices
• 1.5 Market by Application
  • 1.5.1 Global Eye Disorders Treatments Market Share by Application (2014-2025)
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Eye Disorders Treatments Market Size
• 2.2 Eye Disorders Treatments Growth Trends by Regions
  • 2.2.1 Eye Disorders Treatments Market Size by Regions (2014-2025)
  • 2.2.2 Eye Disorders Treatments Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Eye Disorders Treatments Market Size by Manufacturers
  • 3.1.1 Global Eye Disorders Treatments Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Eye Disorders Treatments Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Eye Disorders Treatments Market Concentration Ratio (CR5 and HHI)
• 3.2 Eye Disorders Treatments Key Players Head office and Area Served
• 3.3 Key Players Eye Disorders Treatments Product/Solution/Service
• 3.4 Date of Enter into Eye Disorders Treatments Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Eye Disorders Treatments Market Size by Type (2014-2019)
• 4.2 Global Eye Disorders Treatments Market Size by Application (2014-2019)

5 United States

• 5.1 United States Eye Disorders Treatments Market Size (2014-2019)
• 5.2 Eye Disorders Treatments Key Players in United States
• 5.3 United States Eye Disorders Treatments Market Size by Type
• 5.4 United States Eye Disorders Treatments Market Size by Application

6 Europe

• 6.1 Europe Eye Disorders Treatments Market Size (2014-2019)
• 6.2 Eye Disorders Treatments Key Players in Europe
• 6.3 Europe Eye Disorders Treatments Market Size by Type
• 6.4 Europe Eye Disorders Treatments Market Size by Application

7 China

• 7.1 China Eye Disorders Treatments Market Size (2014-2019)
• 7.2 Eye Disorders Treatments Key Players in China
• 7.3 China Eye Disorders Treatments Market Size by Type
• 7.4 China Eye Disorders Treatments Market Size by Application

8 Japan

• 8.1 Japan Eye Disorders Treatments Market Size (2014-2019)
• 8.2 Eye Disorders Treatments Key Players in Japan
• 8.3 Japan Eye Disorders Treatments Market Size by Type
• 8.4 Japan Eye Disorders Treatments Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Eye Disorders Treatments Market Size (2014-2019)
• 9.2 Eye Disorders Treatments Key Players in Southeast Asia
• 9.3 Southeast Asia Eye Disorders Treatments Market Size by Type
• 9.4 Southeast Asia Eye Disorders Treatments Market Size by Application

10 India

• 10.1 India Eye Disorders Treatments Market Size (2014-2019)
• 10.2 Eye Disorders Treatments Key Players in India
• 10.3 India Eye Disorders Treatments Market Size by Type
• 10.4 India Eye Disorders Treatments Market Size by Application

11 Central & South America

• 11.1 Central & South America Eye Disorders Treatments Market Size (2014-2019)
• 11.2 Eye Disorders Treatments Key Players in Central & South America
• 11.3 Central & South America Eye Disorders Treatments Market Size by Type
• 11.4 Central & South America Eye Disorders Treatments Market Size by Application

12 International Players Profiles

• 12.1 Abbott Medical Optics
  • 12.1.1 Abbott Medical Optics Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Eye Disorders Treatments Introduction
  • 12.1.4 Abbott Medical Optics Revenue in Eye Disorders Treatments Business (2014-2019)
  • 12.1.5 Abbott Medical Optics Recent Development
• 12.2 Novartis
  • 12.2.1 Novartis Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Eye Disorders Treatments Introduction
  • 12.2.4 Novartis Revenue in Eye Disorders Treatments Business (2014-2019)
  • 12.2.5 Novartis Recent Development
• 12.3 Alimera Sciences
  • 12.3.1 Alimera Sciences Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Eye Disorders Treatments Introduction
  • 12.3.4 Alimera Sciences Revenue in Eye Disorders Treatments Business (2014-2019)
  • 12.3.5 Alimera Sciences Recent Development
• 12.4 Teva Pharmaceutical
  • 12.4.1 Teva Pharmaceutical Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Eye Disorders Treatments Introduction
  • 12.4.4 Teva Pharmaceutical Revenue in Eye Disorders Treatments Business (2014-2019)
  • 12.4.5 Teva Pharmaceutical Recent Development
• 12.5 Eyetech Pharmaceuticals
  • 12.5.1 Eyetech Pharmaceuticals Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Eye Disorders Treatments Introduction
  • 12.5.4 Eyetech Pharmaceuticals Revenue in Eye Disorders Treatments Business (2014-2019)
  • 12.5.5 Eyetech Pharmaceuticals Recent Development
• 12.6 Refocus Group
  • 12.6.1 Refocus Group Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Eye Disorders Treatments Introduction
  • 12.6.4 Refocus Group Revenue in Eye Disorders Treatments Business (2014-2019)
  • 12.6.5 Refocus Group Recent Development
• 12.7 VisionCare Ophthalmic Technologies
  • 12.7.1 VisionCare Ophthalmic Technologies Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Eye Disorders Treatments Introduction
  • 12.7.4 VisionCare Ophthalmic Technologies Revenue in Eye Disorders Treatments Business (2014-2019)
  • 12.7.5 VisionCare Ophthalmic Technologies Recent Development
• 12.8 VISX
  • 12.8.1 VISX Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Eye Disorders Treatments Introduction
  • 12.8.4 VISX Revenue in Eye Disorders Treatments Business (2014-2019)
  • 12.8.5 VISX Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer